Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients

Detalles Bibliográficos
Autores principales: Palich, R., Veyri, M., Marot, S., Vozy, A., Gligorov, J., Maingon, P., Marcelin, A.-G., Spano, J.-P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081573/
https://www.ncbi.nlm.nih.gov/pubmed/33932501
http://dx.doi.org/10.1016/j.annonc.2021.04.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081573/
https://www.ncbi.nlm.nih.gov/pubmed/33932501
http://dx.doi.org/10.1016/j.annonc.2021.04.020

Ejemplares similares